SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 81 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 2.65 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $51,000 | -26.1% | 29,511 | -4.3% | 0.00% | -25.0% |
Q2 2015 | $69,000 | +4.5% | 30,842 | -9.4% | 0.00% | 0.0% |
Q1 2015 | $66,000 | +1.5% | 34,052 | +39.4% | 0.00% | 0.0% |
Q4 2014 | $65,000 | -33.7% | 24,422 | -25.0% | 0.00% | -42.9% |
Q3 2014 | $98,000 | -25.8% | 32,567 | +1.3% | 0.01% | -22.2% |
Q2 2014 | $132,000 | -3.6% | 32,164 | +1.5% | 0.01% | -10.0% |
Q1 2014 | $137,000 | -13.8% | 31,701 | +4.2% | 0.01% | -9.1% |
Q4 2013 | $159,000 | – | 30,416 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
Roundview Capital LLC | 21,100 | $91,000 | 0.04% |